FranceOverall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Dermatology & Venereal Diseases
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 101 out of 61,090 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 20,922 | 20,608 |
| Total Cites | 15,913 | 18,373 |
| H-index | 64 | 69 |
| Hm-index | 28 | 30 |
| Number of Single Authored Papers | 19 | 19 |
| Total Cites to Single Authored Papers | 415 | 441 |
| Number of Single+First Authored Papers | 85 | 85 |
| Total Cites to Single+First Authored Papers | 3,412 | 3,818 |
| Number of Single+First+Last Authored Papers | 179 | 179 |
| Total Cites to Single+First+Last Authored Papers | 6,889 | 7,882 |
| Composite Score | 3 | 4 |
| Number of Distinct Citing Papers | 11,421 | 12,466 |
| Ratio of Total Citations to Distinct Citing Papers | 1.39 | 1.47 |
| Self-Citation Percentage |
13.39%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Dermatology & Venereal Diseases
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 93 out of 57,585 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 20,466 | 20,236 |
| Total Cites | 14,805 | 17,108 |
| H-index | 62 | 67 |
| Hm-index | 28 | 30 |
| Number of Single Authored Papers | 19 | 19 |
| Total Cites to Single Authored Papers | 395 | 421 |
| Number of Single+First Authored Papers | 84 | 84 |
| Total Cites to Single+First Authored Papers | 3,258 | 3,657 |
| Number of Single+First+Last Authored Papers | 176 | 176 |
| Total Cites to Single+First+Last Authored Papers | 6,555 | 7,525 |
| Composite Score | 3 | 4 |
| Number of Distinct Citing Papers | 10,636 | 11,596 |
| Ratio of Total Citations to Distinct Citing Papers | 1.39 | 1.48 |
| Self-Citation Percentage |
13.46%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Dermatology & Venereal Diseases
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 88 out of 51,411 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 18,903 | 18,960 |
| Total Cites | 12,662 | 14,541 |
| H-index | 59 | 63 |
| Hm-index | 27 | 28 |
| Number of Single Authored Papers | 19 | 19 |
| Total Cites to Single Authored Papers | 373 | 398 |
| Number of Single+First Authored Papers | 80 | 80 |
| Total Cites to Single+First Authored Papers | 3,004 | 3,350 |
| Number of Single+First+Last Authored Papers | 167 | 167 |
| Total Cites to Single+First+Last Authored Papers | 6,022 | 6,876 |
| Composite Score | 3 | 4 |
| Number of Distinct Citing Papers | 9,065 | 9,850 |
| Ratio of Total Citations to Distinct Citing Papers | 1.40 | 1.48 |
| Self-Citation Percentage |
12.92%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Dermatology & Venereal Diseases
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 85 out of 41,196 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 17,871 | 18,279 |
| Total Cites | 10,909 | 12,492 |
| H-index | 56 | 59 |
| Hm-index | 26 | 27 |
| Number of Single Authored Papers | 18 | 18 |
| Total Cites to Single Authored Papers | 339 | 364 |
| Number of Single+First Authored Papers | 78 | 78 |
| Total Cites to Single+First Authored Papers | 2,747 | 3,065 |
| Number of Single+First+Last Authored Papers | 163 | 163 |
| Total Cites to Single+First+Last Authored Papers | 5,448 | 6,236 |
| Composite Score | 3 | 4 |
| Number of Distinct Citing Papers | 7,830 | 8,461 |
| Ratio of Total Citations to Distinct Citing Papers | 1.39 | 1.48 |
| Self-Citation Percentage |
12.67%
|
|
Trending Researchers
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.